• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉搭桥手术后的血栓形成基因多态性与术后结局

Thrombotic gene polymorphisms and postoperative outcome after coronary artery bypass graft surgery.

作者信息

Emiroglu Ozan, Durdu Serkan, Egin Yonca, Akar Ahmet R, Alakoc Yesim D, Zaim Cagin, Ozyurda Umit, Akar Nejat

机构信息

Department of Cardiovascular Surgery, Nicosia State Hospital, Nalbantoglu Lefkosa Devlet Hastanesi, Ortakoy, Nicosia, Cyprus.

出版信息

J Cardiothorac Surg. 2011 Sep 28;6:120. doi: 10.1186/1749-8090-6-120.

DOI:10.1186/1749-8090-6-120
PMID:21955693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3191480/
Abstract

BACKGROUND

Emerging perioperative genomics may influence the direction of risk assessment and surgical strategies in cardiac surgery. The aim of this study was to investigate whether single nucleotide polymorphisms (SNP) affect the clinical presentation and predispose to increased risk for postoperative adverse events in patients undergoing coronary artery bypass grafting surgery (CABG).

METHODS

A total of 220 patients undergoing first-time CABG between January 2005 and May 2008 were screened for factor V gene G1691A (FVL), prothrombin/factor II G20210A (PT G20210A), angiotensin I-converting enzyme insertion/deletion (ACE-ins/del) polymorphisms by PCR and Real Time PCR. End points were defined as death, myocardial infarction, stroke, postoperative bleeding, respiratory and renal insufficiency and event-free survival. Patients were compared to assess for any independent association between genotypes for thrombosis and postoperative phenotypes.

RESULTS

Among 220 patients, the prevalence of the heterozygous FVL mutation was 10.9% (n = 24), and 3.6% (n = 8) were heterozygous carriers of the PT G20210A mutation. Genotype distribution of ACE-ins/del was 16.6%, 51.9%, and 31.5% in genotypes I/I, I/D, and D/D, respectively. FVL and PT G20210A mutations were associated with higher prevalence of totally occluded coronary arteries (p < 0.001). Furthermore the risk of left ventricular aneurysm formation was significantly higher in FVL heterozygote group compared to FVL G1691G (p = 0.002). ACE D/D genotype was associated with hypertension (p = 0.004), peripheral vascular disease (p = 0.006), and previous myocardial infarction (p = 0.007).

CONCLUSIONS

FVL and PT G20210A genotypes had a higher prevalence of totally occluded vessels potentially as a result of atherothrombotic events. However, none of the genotypes investigated were independently associated with mortality.

摘要

背景

新兴的围手术期基因组学可能会影响心脏手术风险评估的方向和手术策略。本研究的目的是调查单核苷酸多态性(SNP)是否会影响冠状动脉旁路移植术(CABG)患者的临床表现,并使其术后发生不良事件的风险增加。

方法

对2005年1月至2008年5月期间首次接受CABG的220例患者,通过聚合酶链反应(PCR)和实时荧光定量PCR检测凝血因子V基因G1691A(FVL)、凝血酶原/因子II G20210A(PT G20210A)、血管紧张素I转换酶插入/缺失(ACE-ins/del)多态性。终点定义为死亡、心肌梗死、中风、术后出血、呼吸和肾功能不全以及无事件生存期。对患者进行比较,以评估血栓形成基因型与术后表型之间的任何独立关联。

结果

在220例患者中,FVL杂合突变的患病率为10.9%(n = 24),PT G20210A突变的杂合携带者为3.6%(n = 8)。ACE-ins/del的基因型分布在I/I、I/D和D/D基因型中分别为16.6%、51.9%和31.5%。FVL和PT G20210A突变与完全闭塞冠状动脉的较高患病率相关(p < 0.001)。此外,与FVL G1691G相比,FVL杂合子组左心室动脉瘤形成的风险显著更高(p = 0.002)。ACE D/D基因型与高血压(p = 0.004)、外周血管疾病(p = 0.006)和既往心肌梗死(p = 0.007)相关。

结论

FVL和PT G20210A基因型完全闭塞血管的患病率较高,这可能是动脉粥样硬化血栓形成事件的结果。然而,所研究的基因型均与死亡率无独立关联。

相似文献

1
Thrombotic gene polymorphisms and postoperative outcome after coronary artery bypass graft surgery.冠状动脉搭桥手术后的血栓形成基因多态性与术后结局
J Cardiothorac Surg. 2011 Sep 28;6:120. doi: 10.1186/1749-8090-6-120.
2
Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.炎症性肠病患儿中凝血因子V G1691A(莱顿)、凝血酶原G20210A及亚甲基四氢叶酸还原酶C677T血栓形成倾向突变的患病率。
J Pediatr Gastroenterol Nutr. 2002 Nov;35(5):629-35. doi: 10.1097/00005176-200211000-00008.
3
Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis--evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation.儿童自发性静脉血栓形成中的凝血因子V G1691A和凝血酶原G20210A——凝血因子V G1691A和凝血酶原G20210A突变携带者年龄依赖性血栓形成起始的证据
Eur J Pediatr. 1999 Dec;158 Suppl 3:S105-8. doi: 10.1007/pl00014335.
4
Analysis of prothrombotic mutations and polymorphisms in children who developed thrombosis in the perioperative period of congenital cardiac surgery.先天性心脏手术围手术期发生血栓形成的儿童中促血栓形成突变和多态性的分析。
Cardiol Young. 2005 Feb;15(1):19-25. doi: 10.1017/S1047951105000053.
5
Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis.成人土耳其血栓患者的两种常见遗传性血栓形成危险因素:凝血因子V莱顿突变和凝血酶原G20210A突变
Am J Hematol. 2001 Jun;67(2):107-11. doi: 10.1002/ajh.1087.
6
Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.表面健康的约旦人中因子V G1691A(莱顿)和凝血酶原G20210A基因多态性的患病率。
Neuro Endocrinol Lett. 2007 Oct;28(5):699-703.
7
Factor V Leiden and prothrombin G20210A mutations in Thai patients awaiting kidney transplant.等待肾移植的泰国患者中的凝血因子V莱顿突变和凝血酶原G20210A突变
Southeast Asian J Trop Med Public Health. 2002 Dec;33(4):869-71.
8
Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.凝血酶原多态性A19911G、凝血因子V HR2单倍型A4070G、纤溶酶原激活物抑制剂-1多态性4G/5G与视网膜静脉阻塞风险
Ophthalmic Genet. 2017 Sep-Oct;38(5):413-417. doi: 10.1080/13816810.2016.1244694. Epub 2017 Jan 13.
9
Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.印度中部镰状细胞病患者中因子 V 莱顿、凝血酶原 G20210A 和 MTHFR C677T 突变的临床影响。
Eur J Haematol. 2013 Nov;91(5):462-6. doi: 10.1111/ejh.12190. Epub 2013 Sep 16.
10
Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort.土耳其队列中早产儿视网膜病变患者因子V莱顿、凝血酶原G20210A、亚甲基四氢叶酸还原酶C677T和亚甲基四氢叶酸还原酶A1298C基因多态性的评估
Ophthalmic Genet. 2016 Dec;37(4):415-418. doi: 10.3109/13816810.2015.1126611. Epub 2016 Mar 28.

引用本文的文献

1
Acute Myocardial Infarction in Patients with Hereditary Thrombophilia-A Focus on Factor V Leiden and Prothrombin G20210A.遗传性易栓症患者的急性心肌梗死——聚焦于凝血因子V莱顿突变和凝血酶原G20210A突变
Life (Basel). 2023 Jun 12;13(6):1371. doi: 10.3390/life13061371.
2
Biomarkers in Coronary Artery Bypass Surgery: Ready for Prime Time and Outcome Prediction?冠状动脉旁路移植手术中的生物标志物:是否已准备好用于预测结果?
Front Cardiovasc Med. 2016 Jan 5;2:39. doi: 10.3389/fcvm.2015.00039. eCollection 2015.
3
Polymorphisms in glutathione S-transferase are risk factors for perioperative acute myocardial infarction after cardiac surgery: a preliminary study.谷胱甘肽 S-转移酶多态性是心脏手术后围手术期急性心肌梗死的危险因素:初步研究。
Mol Cell Biochem. 2014 Apr;389(1-2):79-84. doi: 10.1007/s11010-013-1929-7. Epub 2014 Jan 17.
4
A single nucleotide polymorphism in the p27(Kip1) gene is associated with primary patency of lower extremity vein bypass grafts.p27(Kip1) 基因中的单核苷酸多态性与下肢静脉旁路移植术的初始通畅率相关。
J Vasc Surg. 2013 May;57(5):1179-85.e1-2. doi: 10.1016/j.jvs.2012.11.040. Epub 2013 Jan 9.

本文引用的文献

1
Factor V 1691 G-A mutation distribution in a healthy Turkish population.健康土耳其人群中凝血因子V 1691 G-A突变分布情况
Turk J Haematol. 2009 Mar 5;26(1):9-11.
2
Gene polymorphisms in APOE, NOS3, and LIPC genes may be risk factors for cardiac adverse events after primary CABG.载脂蛋白E(APOE)、一氧化氮合酶3(NOS3)和脂蛋白酯酶(LIPC)基因的多态性可能是初次冠状动脉旁路移植术(CABG)后发生心脏不良事件的危险因素。
J Cardiothorac Surg. 2009 Aug 19;4:46. doi: 10.1186/1749-8090-4-46.
3
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery.胸外科医师协会2008年心脏手术风险模型:第1部分——冠状动脉搭桥手术
Ann Thorac Surg. 2009 Jul;88(1 Suppl):S2-22. doi: 10.1016/j.athoracsur.2009.05.053.
4
Thrombophilia in cardiac surgery-patients with symptomatic factor V Leiden.心脏手术中的血栓形成倾向——有症状的因子V莱顿突变患者
J Card Surg. 2009 Jul-Aug;24(4):379-82. doi: 10.1111/j.1540-8191.2008.00761.x.
5
A HapMap harvest of insights into the genetics of common disease.从HapMap中获取对常见疾病遗传学的深刻见解。
J Clin Invest. 2008 May;118(5):1590-605. doi: 10.1172/JCI34772.
6
Influence of angiotensin-I-converting-enzyme insertion/deletion gene polymorphism on perioperative hemodynamics after coronary bypass graft surgery.血管紧张素转换酶插入/缺失基因多态性对冠状动脉搭桥术后围手术期血流动力学的影响。
J Cardiovasc Surg (Torino). 2008 Apr;49(2):255-60.
7
Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls.冠心病中的七种止血基因多态性:对66155例病例和91307例对照的荟萃分析。
Lancet. 2006 Feb 25;367(9511):651-8. doi: 10.1016/S0140-6736(06)68263-9.
8
New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics.心血管医学的新范式:新兴技术与实践:围手术期基因组学
J Am Coll Cardiol. 2005 Dec 6;46(11):1965-77. doi: 10.1016/j.jacc.2005.08.040. Epub 2005 Nov 9.
9
Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery.基因多态性与冠状动脉搭桥手术后肾损伤风险的关联。
Am J Kidney Dis. 2005 Mar;45(3):519-30. doi: 10.1053/j.ajkd.2004.11.021.
10
Renin-angiotensin system and haemostasis gene polymorphisms and outcome after coronary artery bypass graft surgery.肾素-血管紧张素系统与止血基因多态性及冠状动脉搭桥手术后的结局
Int J Cardiol. 2005 Jan;98(1):133-9. doi: 10.1016/j.ijcard.2004.03.058.